Completed Trials
CYTOFLOC: Cytosponge™ for post‐chemoradiation surveillance of oesophageal cancer
CYTOFLOC: Cytosponge™ for post‐chemoradiation surveillance of oesophageal cancer
FRONTIER: Fluciclovine (18F) imaging of breast cancer
FRONTIER: An open-labelled study to characterise Fluciclovine (18F) uptake measured by positron emission tomography in breast cancer
TARDOX: Targeted chemotherapy using focused ultrasound for liver tumours
TARDOX :A Proof of Concept Study to Investigate the Feasibility of Targeted Release of Doxorubicin from Lyso-thermosensitive Liposomal (LTSL) Doxorubicin (ThermoDox®) Using Focused Ultrasound in Patients with Primary or Secondary Liver Tumours
CAMELLIA: Anti-CD47 antibody terapy in relapsed/refractory Haematological Malignancies
CAMELLIA: A Phase I dose escalation trial of the Humanized Anti-CD47 Monoclonal Antibody Hu5F9-G4 in Acute Myeloid Leukaemia
ATOM: Atovaquone as Tumour HypOxia Modifier
ATOM: Pre-operative window of opportunity study of the effects of atovaquone on hypoxia in non-small cell lung carcinoma.